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Abstract
Progenitor cell therapies show great promise, but their potential for clinical applications requires improved storage and
transportation. Desiccated cells stored at ambient temperature would provide economic and practical advantages over
approaches employing cell freezing and subzero temperature storage. The objectives of this study were to assess a method
for loading the stabilizing sugar, trehalose, into hematopoietic stem and progenitor cells (HPC) and to evaluate the effects
of subsequent freeze-drying and storage at ambient temperature on differentiation and clonogenic potential. HPC were
isolated from human umbilical cord blood and loaded with trehalose using an endogenous cell surface receptor, termed
P2Z. Solution containing trehalose-loaded HPC was placed into vials, which were transferred to a tray freeze-dryer and
removed during each step of the freeze-drying process to assess differentiation and clonogenic potential. Control groups
for these experiments were freshly isolated HPC. Control cells formed 14506230 CFU-GM, 4306140 BFU-E, and 50640 CFU-
GEMM per 50 mL. Compared to the values for the control cells, there was no statistical difference observed for cells removed
at the end of the freezing step or at the end of primary drying. There was a gradual decrease in the number of CFU-GM and
BFU-E for cells removed at different temperatures during secondary drying; however, there were no significant differences
in the number of CFU-GEMM. To determine storage stability of lyophilized HPC, cells were stored for 4 weeks at 25uC in the
dark. Cells reconstituted immediately after lyophilization produced 580690 CFU-GM (,40%, relative to unprocessed
controls p,0.0001), 170670 BFU-E (,40%, p,0.0001), and 41622 CFU-GEMM (,82%, p=0.4171), and cells reconstituted
after 28 days at room temperature produced 5136170 CFU-GM (,35%, relative to unprocessed controls, p,0.0001),
112668 BFU-E (,26%, p,0.0001), and 36617 CFU-GEMM (,82%, p=0.2164) These studies are the first to document high
level retention of CFU-GEMM following lyophilization and storage for 4 weeks at 25uC. This type of flexible storage stability
would potentially permit the ability to ship and store HPC without the need for refrigeration.
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Introduction
Hematopoietic stem and progenitor cells (HPC) contain
populations of cells with long-term and short-term regeneration
capacities as well as committed progenitors. HPC give rise to all
the blood cell types including lymphoid (T-cells, B-cells, NK-cells,
dendritic) and myeloid (monocyctes/macrophages, neutrophils,
megakaryocytes, granulocytes, eosinophils, erythrocytes)[1]. These
cells can be isolated from bone marrow, peripheral blood, or
human umbilical cord blood (UCB) and have been shown to be
valuable for treatment of a wide variety of human diseas-
es[2,3,4,5,6,7,8]. As a result, there is a growing need for
producing, storing and shipping large numbers of HPC to ensure
a steady supply for use in clinical applications. Simple preservation
techniques, such as refrigeration or tissue culture, have drawbacks
including limited shelf life, high cost and risk of contamination.
Alternatively, cryopreservation has been successfully utilized for
long-term storage of HPC. This approach is based on the principle
that chemical, biological and physical processes are sufficiently
‘‘suspended’’ at cryogenic temperatures (2196uC) because liquid
water does not exist below 2130uC[9]. In fact, the only physical
states that exist at cryogenic temperature are crystalline or glassy
(also called amorphous), and in both the viscosity is so high ($10
13
poise) that the rates of diffusion controlled reactions are
insignificant on practical time scales[10,11,12]. Furthermore,
there is insufficient thermal energy for chemical and metabolic
processes to proceed at practical relevant rates[9,13].
Conventionally, cryopreservation protocols employ high relative
concentrations (e.g., 1.0–2.0 M) of cryoprotectants such as
dimethyl sulfoxide (DMSO), glycerol or ethylene glycol[9,14]
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protection to the intracellular components. Some complications
associated with the use of these permeable cryoprotectants include
an exceptionally low glass transition temperature (,283uC)[15].
Low glass transition temperatures require tight control of
temperature during product storage and transfer. Thermal
excursions or storage above the glass transition temperature
results in an increase in motion as a result of the large decrease in
matrix viscosity. Decreased viscosity allows diffusion to occur and
can result in degradation of frozen cells and tissues[9,16,17,18].
More importantly, freezing media containing DMSO have
shown to be toxic to patients[19,20,21,22,23]. Efforts to reduce
toxicity include the removal of DMSO prior to transfusion or
decreasing the amounts used in the freezing process[24,25,26]. An
alternative to DMSO includes nontoxic sugars such as trehalose.
Trehalose is a non-toxic, non-reducing disaccharide of glucose
that possesses an exceptional ability to stabilize and preserve cells
and cellular structures during freezing[14,27,28,29,30] and
drying[31,32]. The utility of trehalose as a cryoprotectant has
been attributed to its protective interactions with lipid membranes,
stabilization of labile proteins during freezing-thawing, its
chemical stability and the ability to form stable glasses during
cooling of cells for cryopreservation[31,32,33,34,35,36,37]. For
cell preservation, formation of a glassy matrix in the cell’s interior
also can contribute to the inhibition of potentially lethal
intracellular ice crystals and minimize cell damage to excessive
concentration of electrolytes. One obstacle in the utility of
trehalose as a cryoprotectant is overcoming its impermeability to
mammalian cell membranes, which has been investigated
extensively[31,38,39,40,41,42,43,44,45,46,47].
As a first step toward preserving HPC by freeze drying, we
previously investigated the permeabilization of a model cell line
(TF-1) to trehalose[48]. TF-1 cells are CD34 positive, cytokine-
dependent, and retain the ability to differentiate into erythroid,
monocytic and megakaryocytic lineages following appropriate
stimulation[49,50,51,52,53]. These characteristics make them an
appropriate surrogate for primary HPC in evaluating the effects of
the critical processing steps. TF-1 cells were permeabilized to
trehalose using an endogenous cell surface receptor, termed
P2Z[54,55,56], which is synonymous with P2X7 [57]. In the
presence of millimolar concentrations of extracellular uncom-
plexed adenosine-5-triphosphate (e.g., ATP
42), this protein forms
nonselective pores that render plasma membranes permeable to
small molecules (e.g., MW#900 Da)[58,59,60]. This effect is
reversed by a ten-fold dilution (to reduce the ATP concentration)
and the addition of magnesium to complex with ATP, so that cells
can be permeabilized transiently[61]. The average number of TF-
1cells positive for the P2Z receptor was approximately 86%. Cells
loaded with 200 mM (6.8% w/v) trehalose were frozen and stored
at 280uC for 4 months. Following storage, thawed cells were
evaluated for differentiation capacity and clonogenic output.
Results obtained with this technique were compared to conven-
tional freezing protocols using 10% (v/v, 1.4 mM) dimethyl
sulfoxide (DMSO). Colony forming units (CFU) generated from
cells frozen with intra- and extracellular trehalose were essentially
equivalent in size, morphology, and number (,91%) to those
generated from unfrozen cells. Furthermore, there were no
significant alterations in phenotypic markers of differentiation
(CD34, CD33, and CD235a), activation (CD38), and proliferation
(CD71). The P2Z receptor is expressed in many hematopoietic
cells including myeloid progenitors, CD34
+ peripheral blood
progenitor cells as well as neutrophils, dendritic, granulocytes,
monocytes/macrophages, lymphocytes, and erythrocytes
[58,62,63,64].
In this study we explore the ability of intra- and extracellular
trehalose to protect human HPC during freezing, drying and
storage at room temperature for 4 weeks. To ensure maximum
uptake of sugar, cells were permeabilized via the P2Z receptor with
two different types of porating agent: ATP and benzoyl ATP
(BzATP), a more potent agonist. Successful preservation criteria for
HPC include retaining the ability to form colonies in semi-solid
culture medium and the capability of differentiating to multiple
lineages. More mature progenitor cells are capable of forming
colong forming unit-erythroid (CFU-E), burst forming units-
erythroid (BFU-E), colony forming unit-granulocyte (CFU-G),
megakaryocyte (CFU-Mk), and colony forming unit-granulocyte
monocyte/macrophage (CFU-GM), a heterogeneous population of
macrophages and granulocytes. Colonies comprised of granulocyte-
erythroid-megakaryocyte-macrophage (CFU-GEMM) represent a
primitive multi-lineage myeloid progenitor cell that are present in
UCB in relatively high numbers compared to more mature
cells[1,65,66]. The number of CFU observed can vary depending
on the frequency of individual lineage-specific progenitor cells
present in UBC obtained from individual subjects and the specific
culture conditions. In addition, variability in the number of CFU
may occur because we did not quantify nor isolate and identify the
types of cells that were positive for the P2Z receptor.
To maximize cell survival during freeze-drying and subsequent
storage, it also is important to obtain an optimal residual water
content and a sufficiently high glass transition temperature (Tg) to
permit long-term storage ambient storage. Therefore, we also
investigated the effects of lyophilization processing steps and
resulting residual water content on both cell survival and Tg.
Materials and Methods
Reagents
Sodium bicarbonate, ammonium chloride, sodium ethylenedia-
minetetracetic acid (EDTA), 2,3-(4-benzoyl) benzoyl adenosine-5-
triphosphate (BzATP) and adenosine-5-triphosphate were pur-
chased from Sigma (St. Louis, MO). Trypan blue, phosphate
buffered saline (PBS) without calcium and magnesium, fetal bovine
serum (FBS) and Lymphocyte Separation Medium (density
=1.077 g/mL) were purchased from Fisher Scientific (Atlanta,
GA). MethoCultH Classic was purchased from Stem Cell
Technologies (Seattle, WA). Hydroxyethyl starch (Viastarch,
HES) was purchased from Fresenius (Linz, Austria). The HES
mean molecular weight, water content, and NaCl content were
259,700 Da, 4.64% and 0.11%, respectively[67]. Bovine serum
albumin fraction-V 30% (BSA) was purchased from Gemini
BioProducts (West Sacramento, CA). Low endotoxin glucose and
trehalose were purchased from Pfanstiehl Laboratories (Wauke-
gan, Illinois). Fluorescein-5-isothiocyanate isomer I (FITC) and
propidium iodide (PI) was purchased from Molecular Probes
(Eugene, OR).
Red blood cell lysis buffer
8.3 g ammonium chloride, 1.0 g sodium bicarbonate, and
0.04 g sodium EDTA were dissolved in 1 L ultra pure sterile
water. The solution was filter through 0.22 mM filter and stored at
4uC. Red blood cell (RBC) lysis buffer was warmed to 37uC before
use.
Isolation HPC from human umbilical cord blood
All protocols were approved by the University of Colorado
Health Sciences Center Internal Review Board (number 01-809).
After informed consent, human cord bloods were obtained using
sterile tubes with heparin from newborn umbilical cords following
Freeze Drying Human HPC
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was available if required or a copy in the native language of the
patient was made available as requested. Only UCB that tested
negative for HIV were used in this study. Samples were processed
within 12 hr of collection.
Cord blood specimens were diluted with an equal volume of
RBC lysis buffer and transferred to a 50 mL conical tube. Each
specimen tube was then rinsed with 2 mL of RBC lysis buffer and
the rinse was added to specimens. Specimens were briefly vortexed
and then incubated for 3 minutes at room temperature. Cells were
pelleted by centrifugation at 1500 rpm for 10 minutes. The
supernatant was decanted and cells were resuspended in PBS/
1%BSA equivalent the original specimen volume.
Light-density mononuclear cells (MNC) were isolated by
layering cell suspension carefully onto Lymphocyte Separation
Medium (density=1.077 g/mL, 2 volumes of diluted blood to 1
volume of separation medium) and centrifuging at 1500 rpm for
30 minutes at room temperature. MNC (monocytes and
lymphocytes) have a lower buoyant density than the erythrocytes
and the polymorphonuclear (PMN) leukocytes (granulocytes).
Since the majority of MNC have densities below 1.077 g/mL,
they can be isolated at the sample/medium interface. The
interphase layer containing MNC was collected and washed twice
with PBS/1%BSA. After 2 cycles of washing and centrifugation,
cell pellets were resuspended in 5 mL of PBS/1%BSA. Cells were
counted using a Coulter Counter, and cell viability was assessed by
Trypan blue exclusion. No further cell identification or purifica-
tion was performed.
MNC cells were cultured with MethoCultH Classic. Cytokines
in this medium only support cells that give rise to CFU-E, BFU-E,
CFU-GM, and CFU-GEMM. All references to these cells will be
identified as HPC in the text. (See CFU assay for details)
Expression of P2Z Receptor on mononuclear cells
Expression of P2Z receptor was measured by permeabilizing
HPC with BD Cytofix/Cytoperm kit (BD Biosciences Pharmin-
gen, San Diego, CA) using manufacturer’s instructions, staining
with anti-P2Z/P2X7 receptor (Calbiochem, La Jolla, CA)
polyclonal antibody from rabbit and anti-Rabbit-PE secondary
antibody developed in goat (Sigma, St. Louis, MO). Briefly, 1610
6
cells were washed twice with 1 mL of staining buffer (PBS/1%
FBS/5% (w/v) sodium azide). To fix cells, HPC were pelleted by
centrifugation (1100 rpm for 8 minutes) and then resuspended in
250 mL of BD Cytofix/Cytoperm solution for 30 minutes at 4uC.
HPC were washed twice in 1 ml of 1X BD Perm/Wash solution.
Cells were then resuspended in 50 mL of BD Perm/Wash solution
containing anti-P2Z/P2X7 (1:100) for 30 minutes at 4uC. Cells
were washed twice in 1 mL of 1X BD Perm/Wash solution. Cells
were then resuspended in 50 mL of 1X BD Perm/Wash solution
containing 20 mL of anti-Rabbit-PE for 30 minutes at 4uC in the
dark. Cells were washed twice in 1 mL staining buffer. Cells were
then resuspended in 300 mL of staining buffer and stored at 4uCi n
the dark until flow cytometric analysis. Flow cytometric analysis
was performed a Coulter Epics XL equipped with Summit v3.1
and v4 software.
Cell poration and trehalose loading
HPC were incubated in poration buffer containing 100 mM
BzATP or 5 mM ATP and 200 mM trehalose at a concentration
of 1610
6 cells in 1 mL. Poration buffer is composed of 5 mM
glucose, 1X essential amino acids, 1X nonessential amino acids
and 1X Vitamin Stock in 10 mM K2HPO4/KH2PO
4 titrated to
pH 7.4560.03 (modified from Menze[68]. Cells were incubated
in the reaction mixture for 0–90 min to accommodate trehalose
loading. Pores were closed with the addition of 1 mM MgSO4 and
10-fold dilution of BzATP or ATP using RPMI 1640.
Poration efficiency for HPC was assessed by FITC/PI staining
using flow cytometry as previously described[48,69,70,71,72]. A
stock solution of FITC for permeabilization studies was prepared
by dissolving 1 mg FITC in 1 mL of DMSO, with further dilution
to 0.1 mg/mL using PBS without calcium and magnesium.
Briefly, porated cells were loaded with trehalose containing
100 mL of 0.1 mg/mL FITC. Pores were closed and excess dye
was removed by washing twice with PBS/1%FBS. Approximately
1610
5 porated cells were removed and suspended in 500 mLo f
PBS/1%FBS. Cells were treated with 10 mL of 1.0 mg/mL PI, a
membrane-impermeant dye, for 4 min prior to analysis. PI labels
the nucleic acids of membrane-compromised cells. Cells which
stained positive for FITC and negative for PI were gated and
considered to be both viable and porated, whereas cells stained
with PI were gated and considered to be dead. All reported values
were normalized to total cell count. Flow cytometric analysis was
performed on a Coulter Epics XL equipped with System II
software.
Lyophilization
After trehalose loading, HPC were lyophilized in a formulation
containing 6.8% trehalose/2% HES/5% HSA (w/v). Approxi-
mately 1 mL of sample solution was transferred to 5-mL flat
bottom borosilicate lyophilization vials (West Pharmaceutical,
Lititz, PA), and the vials were placed on the shelf of an FTS
DuraStop MP/DuraDry MP freeze-dryer (Stone Ridge, NY). The
shelf was cooled from room temperature to 245uC at a cooling
rate of 2.5uC/min until product temperature reached 245uC.
Samples were maintained 245uC for 180 minutes. Primary drying
was initiated by raising the shelf temperature from 245uCt o
235uC at 2.5uC/ minute, reducing the chamber pressure to
80 mTorr and maintaining the shelf temperature at 235uC for
2160 minutes. To determine completion of primary drying, the
step was monitored using the chamber pressure rise test and
equilibration of the product temperature to the shelf temperature,
as described previously[69,70]. For secondary drying, samples
were warmed by increasing the shelf temperature at a rate of
0.2uC/minute to the designated secondary drying temperature to
be tested and maintaining the shelf at this temperature for 360
minutes. To determine where clonogenic and differentiation
potential is lost during lyophilization, vials were removed at the
end of primary drying (235uC) and during secondary drying (at
5u,1 0 u,1 5 u, and 20uC) from the freeze-drying chamber into an
antechamber using a retractable arm. The extracted vials were
stoppered in the antechamber under the same pressure as the
chamber (,80 mTorr). At the end of the cycle, the trays were
raised until the rubber stoppers were pushed down to seal the vials
under vacuum before removing them from the unit. All samples
were stored at 280uC until analysis.
Rehydration
Lyophilized samples were rapidly reconstituted using high
purity water. An aliquot of ,950 mL water was drawn into a 1 mL
serological pipette, and the water was released down the sides of
lyophilization vials. To ensure homogeneous resuspension of the
cells, the solution containing the cells was then gently drawn into a
1 mL serological pipette and released down the sides of the vials 5-
times. Approximately 2 mL of complete medium was added to
each vial, and cells were transferred to 10 cm
2 flat bottom tube
flasks (MidWest Scientific, St. Louis, MO), and incubated for 2 hr
at 37uC in humidified air containing 5% CO2 before plating cells
in methylcellulose.
Freeze Drying Human HPC
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Progenitor cell proliferation of control, frozen and thawed or
freeze dried, and rehydrated cells was quantified by an in vitro
method using MethoCultH Classic, a semi-solid methylcellulose
system containing stem cell factor (SCF), GM-CSF, interleukin 3
(IL-3), and erythropoietin (StemCell Technologies, Vancouver,
BC, Canada) and by measuring clonogenic activity via CFU. The
assay was performed with light-density MNC as described above.
Cytokines in this medium only support cells that give rise to CFU-
E, BFU-E, CFU-GM, and CFU-GEMM. The culture plates used
in these studies do not support the growth of anchorage-dependent
cells. All references to these cells will be identified as HPC in this
text.
Unfrozen control cells were suspended at a concentration of
1610
6 cells/mL and 100 mL of cells were removed for culture in
1% methylcellulose. (,1610
5 as determined by both a Coulter
counter and trypan blue exclusion). The 100 mL of cells was added
to 5 mL of 1% methylcellulose (,20,000 cells/mL). The clono-
genic activity of unfrozen control cells was standardized in this
manner and considered to be 100% clonogenic potential. Colony
identification was based on color and morphology. Only multi-
lineage myeloid colonies were scored (i.e., CFU-GEMM, CFU-
GM, or BFU-E).
For freeze-thawing experiments, cell samples were removed at
the end of the freezing step of lyophilization and stored at 280uC
until analysis. Frozen samples were rapidly thawed in a 37uC
water bath. For experiments of cells that were freeze-dried,
samples were stored at 280uC until analysis. Dried samples were
rehydrated as described in the rehydration section above.
Following thawing or rehydration, approximately 2 mL of
complete medium was added to each sample. Cells were mixed
by pipetting with a 5-mL serological pipette 5-times to ensure
homogeneous suspension. Cells were then transferred to 10 cm
2
flat bottom tube flasks (MidWest Scientific, St. Louis, MO) and
incubated for 2 hr at 37uC in humidified air containing 5% CO2.
Following incubation at 37uC, approximately 50 mL of cell
suspension was transferred to a 15-mL conical tube with 6 mL
of 1% methylcellulose containing growth factors.
Four individual culture plates were scored for each group. All
samples were cultured at 37uC in humidified air containing 5%
CO2 for 14 days, after which colonies were enumerated on an
inverted Nikon microscope (1 colony $20 cells).
Tg measurements
All samples were analyzed on a Perkin-Elmer Diamond DSC
equipped with an Intercooler II and the data were analyzed on
Pyris 7.0 software. The DSC was calibrated using indium (for
temperature and enthalpy of melting). Vials containing dried
samples used for Tg measurements were placed in a nitrogen-
purged dry glove box to avoid possible hydration resulting from
exposure to environment and hermetically sealed in aluminum
pans. Approximately 10 mg of solid was measured each
measurement. Lyophilized samples were heated from 0 to 200uC
at100uC/minute, maintained at 200uC for 5 minutes, then cooled
to 0uC and reheated again to 250uC at the same rates to measure
Tg in the second scan. Values are reported as the onset
temperature of the glass transition.
Residual water content
Residual water content of lyophilized samples was determined
by Karl Fischer titration using a Mettler DL37 coulometric
moisture analyzer (Hightstown, NJ) containing pyridine free vessel
solutions (Photovolt Instruments, Inc., St. Louis Park, MN).
Samples were prepared in a nitrogen-purged dry glove box to
avoid possible hydration resulting from exposure to environment.
Lyophilized samples were dissolved in 1 mL of dimethyl
formamide. The samples were sonicated for 15–25 minutes to
ensure complete solubility prior to analysis. Using a gas-tight
syringe, 250 mL were withdrawn through the rubber stopper and
moisture analysis was performed as previously described
70. Values
are reported as mass percent water (gH2O/100 g solid).
Storage stability
After lyophilization, stoppered vials containing dehydrated
samples were sealed with aluminum caps and stored in an
incubator at 25uC (so-called ‘‘controlled room temperature’’) in
the dark for 4 weeks. At the end of the storage period, samples
were rehydrated and analyzed as described above.
Statistical Analysis
Statistical analyses were performed on CFU assay results using
paired-student t test (SigmaPlot 2001) and ANOVA using
Dennett’s test, which controls overall error rate for comparing
all other means with a designated control group’s mean (JMP v6-
8). Differences among groups were considered significant when p
value was less than 0.05. Data reported as the mean 6 the
standard deviation of three independent experiments each with
quadruplicate samples.
Results
Expression of P2ZR and permeabilization of HPC
We investigated the expression of P2Z receptor on HPC using
indirect staining and flow cytometric analysis (Figure 1). Staining
with secondary antibody alone marked the background fluores-
cence level by non-specific binding of this antibody to dead or
other cells (1.6%60.3, Figure 1A). Fluorescence levels above the
background were considered specific for P2Z and shown to be
approximately 58%64% (Figure 1B) compared to secondary
antibody alone (Overlay of A and B as shown in Figure 1C).
To assess poration efficiency, HPC were permeabilized by
exposing them to either 5 mM ATP or 100 mM BzATP, which
opens the P2Z cell surface receptor, in medium containing
200 mM trehalose and 0.1 mg/mL FITC. FITC was employed as
an indicator of poration because it is normally impermeable to
cellular membranes and has a similar molecular mass (MW 389) to
that of trehalose (MW 342). In the absence of porating agent, less
than 1% of cells were positive for the presence of dye. There was a
gradual increase in the number of cells positive dye when
permeabilized in the presence of ATP, reaching a maximum of
,31% after 75 minutes (Figure 1D). Permeabilization in the
presence of BzATP (a more potent agonist for the P2Z receptor
than ATP)[57,60], resulted in a steady increase in the number of
cells positive for dye, with 5864% of cells positive for dye after 90
minutes. The membrane integrity of cells was also monitored
during poration using PI. There was a gradual loss in membrane
integrity after 90 minutes of permeabilization using BzATP as the
porating agent, with 6863% of cells remaining intact whereas
9064.5% of cells remained intact when the porating agent was
ATP. These results indicate that HPC can be permeabilized via
P2Z receptors for up to 60 minutes using BzATP and for up to 90
minutes using ATP without a significant decrease in cell viability.
Effect of intracellular trehalose on the frequency of CFU-
GM, BFU-E, and CFU-GEMM following freeze-thawing
Cells must first survive freezing before freeze-drying can be
attempted. To demonstrate the use of trehalose as an appropriate
intracellular cryoprotectant, we permeabilized cells in medium
Freeze Drying Human HPC
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Trehalose loaded cells were suspended in a formulation containing
6.8% trehalose/2% HES/5%HSA and then slowly cooled
(1uC/minute) to 280uC followed by storage at 280uC for one
week. Cryopreserved cells were rapidly thawed in a 37uC water
bath and tested for clonogenic potential. Control groups for these
experiments were freshly isolated cells and cells cryopreserved with
10% DMSO (1.4 M). As seen in Figure 2, cells cryopreserved
trehalose produced comparable CFU to cells cryopreserved with
DMSO. These data document that primary HPC loaded with
trehalose can survive freeze-thawing when cryopreserved in
medium containing 6.8% extracellular trehalose/2% HES/5%
HSA. Furthermore, the frequency of CFU-GM, BFU-E, and
CFU-GEMM is comparable to results obtained with fresh cells
and those cryopreserved with DMSO.
Effect of lyophilization and reconstitution on frequency
of CFU-GM, BFU-E, and CFU-GEMM
A representative plot of the temperature profile during the
freeze drying cycle shows when vials were removed during
lyophilization without interrupting the cycle to assess the effect of
each step on the differentiation and clonogenic potential of the
cells (Figure 3). Trehalose loaded cells were lyophilized in a
formulation containing 6.8% trehalose/2% HES/5% HSA (w/v).
Samples were removed during processing using an extractable arm
into an antechamber (See methods) and stored at 280uC until
analysis. There were three main types of colonies that were
enumerated: CFU-GM, BFU-E, and CFU-GEMM (Figure 4).
There was no difference in the number of CFU produced by
control groups and cells that were removed at the end of the
freezing step and thawed (Figure 5A). There was a gradual
decrease in the number of CFU-GM and BFU-E for samples
removed at the end of primary drying and during secondary
drying; however, there were no differences in the number of CFU-
Figure 1. Expression of P2Z receptor and dye uptake by porated HPC. (A) Expression of P2Z receptor was measured by immunofluorescence
and analyzed by flow cytometry. Negative control treated with secondary antibody alone signifying non-specific binding or background fluorescence
(approximately 1.660.3%). (B) Cells stained with anti-P2Z/P2X7-PE showed approximately 5864% of HPC cells express the P2Z receptor compared to
negative control. (C) Overlay of panels A and B showing comparison of background fluorescence to cells positive for P2Z. D) Poration efficiency of
HPC: cells permeabilized in the presence of 200 mM trehalose for 0–90 min using 5 mM ATP (Open Circles) and 100 mM BzATP (Closed Circles).
Poration efficiency was quantified by determining FTIC-positive cells with flow cytometry. Membrane integrity following permeabilization using
5 mM ATP (Open Squares) and 100 mM BzATP (Closed Squares) was measured by quantifying propidium iodide-negative cells with flow cytometry.
doi:10.1371/journal.pone.0012518.g001
Figure 2. HPC cell proliferation and differentiation of untreat-
ed and cryopreserved cells. Frequency of CFU-GM (Black Stripes),
BFU-E, (Light Gray Stripes) and CFU-GEMM (Dark Gray Stripes) colonies
following cryopreservation with trehalose were quantified using CFU
assay (see Materials and Methods). Values are represented as the mean
6 standard deviation of the mean of 3 independent experiments for
n=3 subjects with 4 replicates and 4 individual culture plates for each
control or treatment group (1 colony=$20 cells).
doi:10.1371/journal.pone.0012518.g002
Freeze Drying Human HPC
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the means were compared using Dennett’s test, which controls
overall error rate for comparing all other means with a designated
control group’s mean. CFU produced by thawed cells removed at
the end of the freezing step and rehydrated cells removed at the
end of primary drying were not statistically different from that for
control cells. There was a gradual decrease in the number of CFU-
GM and BFU-E produced by cells removed at increasing
temperatures during secondary drying, which were statistically
different from control groups. In marked contrast, cells produced
approximately 82% CFU-GEMM at all secondary drying shelf
temperatures compared to control cells. There were no statistical
differences in the means between CFU-GEMM produced by
rehydrated cells and control cells.
In addition to measuring the differentiation and clonogenic
potential of lyophilized cells, we also quantified the Tg and
residual water content of the dry cake (Figure 5B). Not
surprisingly, the Tg of samples increased as water was removed
from samples. The final Tg of samples processed at a secondary
drying temperature of 20uC was 19763uC.
At the end of the primary drying step, there was approximately
39.560.8 gH2O/100 g solid. As expected, the residual water
content decreased as secondary drying continued, which resulted
in a concomitant decrease in cells’ differentiation and clonogenic
potential. This observation is consistent with results reported by
Toner and colleagues who suggest that there may be an optimal
residual water content required for stable dry cells[31].
Effect of storage for 4 weeks at 25uC on frequency of
CFU-GM, BFU-E, and CFU-GEMM
To determine storage stability of lyophilized HPC, cells dried at
a final secondary drying shelf temperature of 15uC were stored for
4 weeks at 25uC in the dark (Table 1). Cells reconstituted
immediately after lyophilization produced approximately 40%
CFU-GM, 40% BFU-E, and ,82% CFU-GEMM relative to
control. Cells reconstituted on after 28 days of storage at room
temperature produced approximately 35% CFU-GM 26% BFU-
E, and 82% CFU-GEMM compared to control. There was an
initial decrease in the frequency of CFU-GM and BFU-E upon
reconstitution immediately after lyophilization, but there was no
further change in clonogenic output after 4 weeks of storage.
There was not a significant difference in the frequency of CFU-
GEMM by cells stored for 4 weeks at 25uC and untreated control
Figure 3. Representative plot of processing variables. Graph representing processing variables monitored during lyophilization used to
optimize processing conditions. Optimization conditions were determined by testing vials removed during freeze drying cycle. Sample extraction was
performed with a retractable arm via an antechamber equipped with an independent vacuum pump so samples could be removed at the following
shelf temperatures: (1) end of freezing step at 245uC, (2) end of primary drying at 235uC, (3) 5uC during secondary drying, (4) 10uC during secondary
drying, (5) 15uC during secondary drying, and (6) 20uC during secondary drying. Chamber was at ambient temperature and atmospheric pressure
during the freezing step, and approximately 10uC and 80 mTorr during primary and secondary drying.
doi:10.1371/journal.pone.0012518.g003
Figure 4. Representative images of colony forming unit assay
plate and colony scoring. Appearance of: A) Semi-solid methylcel-
lulose containing growth factors (SCF, IL-3, and EPO). B) Colonies scored
as CFU-GEMM, C) Colonies scored as BFU-E, and D) Colonies scored as
CFU-GM.
doi:10.1371/journal.pone.0012518.g004
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secondary drying is the main loss of cells during freeze-drying and
storage in the lyophilized formulation.
Discussion
Requirements for successful stabilization of cells during freezing
and drying include appropriate cryoprotectants and lyoprotectants
to preserve cellular components and the dependent functions.
Endogenous pore forming proteins, such as the P2Z receptor, are
ideal for transport of low molecular weight compounds. P2Z
receptors are activated specifically by the fully ionized form of
ATP (e.g., ATP
42). The pore opening is also temperature and pH
dependent. Optimal conditions for pore formation is 37uC and
pH 8.0–8.5, whereas the pore is inactive below 18uC and at
pH 6.5[73]. To reduce cellular stress during permeabilization, we
loaded trehalose into cells at 37uC in buffer with a pH of 7.45. The
fraction of cells positive for the P2Z receptor was approximately
58%, which indicates that not all HPC derived from UBC express
this pore forming protein. We did not see differences in the
differentiation and clonogenic potential of trehalose-loaded HPC
after freezing and thawing compared to control groups. However,
we did observe a significant difference in differentiation and
clonogenic potential after rehydration of desiccated cells capable
Figure 5. Frequency of CFU-GM, BFU-E and CFU-GEMM colonies obtained following lyophilization and reconstitution. A) HPC
proliferation and differentiation of untreated and lyophilized cells were quantified by CFU assay (see Materials and Methods). Colonies were scoreda s
CFU-GM (Black Stripes), BFU-E (Light Gray Stripes), or CFU-GEMM (Dark Gray Stripes). Values are represented as the mean 6 standard deviation of the
mean (p,0.001) of 3 independent experiments for n=3 subjects with 4 replicates and 4 individual culture plates for each control or treatment group.
*=statistically different from control and other test groups, **=statistically different from control, but not statistically different from each other. B)
Thermal analysis of samples removed during lyophilization. FS=freezing step, PD=primary drying, SD=secondary drying.
doi:10.1371/journal.pone.0012518.g005
Table 1. Storage stability of lyophilized HPC derived from umbilical cord as a function of clonogenic activity.
CFU Type Untreated control
CFU Colonies/50 mL ± SD immediately after
reconstitution
CFU Colonies/50 mL ± SD Storage @ 25uCf o r
4 wks in the dark
CFU-GM 14506230 570690 (,40%) 5106170 CFU-GM (,35%)
BFU-E 4306140 170670 BFU-E (,40%) 112668 BFU-E (,26%)
CFU-GEMM 50640 41622 CFU-GEMM (,82%) 36617 CFU-GEMM (,82%)
HPC were lyophilized in a formulation containing 6.8% trehalose/2% HES/5% HSA (w/v) and stored at 25uC for 4 weeks in the dark. Stability of CFU-GM, BFU-E, and CFU-
GEMM.
doi:10.1371/journal.pone.0012518.t001
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expression of the P2Z receptor may explain the differences
observed in the number of colonies produced by cells before and
after freeze-drying.
To identify at point during during freeze-drying that cells lost
function, we removed samples during the various steps of the
lyophilization process. Lyophilization is a dehydration process
comprising three main steps: freezing, primary drying, and
secondary drying. The purpose of freezing is to separate the
solvent (e.g., water) from the solutes. In a typical aqueous solution,
the a large fraction of water will form ice crystals and the solutes
will be concentrated in the remaining solution between the ice
crystals. As cooling continues, the concentrated non-ice phase
solidifies; yielding an amorphous matrix.
Upon completion of freezing, the lyophilization cycle moves
into the primary drying phase. The main purpose of primary
drying is to remove the water from the formulation by subliming
the ice crystals formed during freezing. Primary drying begins by
reducing the chamber pressure below the vapor pressure of ice and
raising the shelf temperature to supply heat for sublimation of ice.
The ice-gas interface begins at the top of the cake and proceeds
downwards to the bottom of the vial. Upon completion of primary
drying, there is still a considerable amount of residual water
remaining in the formulation.
The purpose of secondary drying is to reduce to remove the
water that did not freeze and in the amorphous phase by
desorption, without compromising the volume of the cake formed
by the partially-dried formulation. Desorption of water is
accomplished by raising the shelf temperature. Secondary drying
is complete when the desired residual water content is achieved for
long-term stability (product and formulation specific).
During the first two steps of lyophilization, there was not a
significant reduction in differentiation and clonogenic potential of
HPC loaded with trehalose. When samples were removed during
secondary drying, only cells capable of producing CFU-GEMM
survived to levels comparable to control groups. ANOVA
performed on results suggests the critical processing step for
BFU-E reduction is during secondary drying at 5uC. CFU
produced by cells exposed to higher secondary drying tempera-
tures were not statistically different from those removed from the
lyophilizer after secondary drying at 5uC. It may be possible to
increase differentiation and clonogenic potential by simply
optimizing the freeze-drying process. The number of CFU-GM
produced by cells removed at 5uC were also significantly different
from control groups. However, there was a gradual decrease in the
number of CFU-GM produced by cells removed downstream
from this time point, suggesting the damage may have occurred at
the onset of secondary drying which result in cumulative losses in
CFU production. These cells may require both cycle optimization
and additional formulation development to increase clonogenic
potential to levels obtained with CFU-GEMM. It is unknown if
CFU-GEMM express a higher number of P2Z receptors, and as a
result, have an increased survival rate due to higher amounts of
intracellular trehalose.
The frequency of BFU-E, CFU-GM, and CFU-GEMM
observed in this study are significantly greater than results
reported previously by Natan and colleagues[74]. In their study,
human UBC were preserved with the antioxidant epigallocatechin
gallate (EGCG) and trehalose added to the medium. Cells were
then frozen using a directional freezing device. The frozen samples
were placed in a Labconco Freezone Plus 6 freeze dryer near the
condenser for 3.5 days. The authors describe this freeze-drying
system as ‘‘a very simple device, in which neither shelf temperature
nor vacuum pressure can be controlled or recorded’’. After
processing, samples were stored at 2–8uC and 25uC for 1 week.
The number of CD34+ cells were quantified by flow cytometric
analysis after thawing frozen samples and rehydrating lyophilized
samples. There were approximately 3.566610
6 and
5.3612.3610
6 CD34+ cells after thawing and rehydration of
lyophilized cells, respectively compared to fresh control
(5.464.7610
6). These CD34+ cells produced 7.83611.69 and
2.5663.43 BFU-E following thawing and rehydration, respectively
compared to control (14.67615.89). The number of CFU-E
produced by CD34+ cells were approximately 29.33638.99 and
18.78614.35 after thawing and rehydration, respectively com-
pared to control (16.3369.29). They did not report any
observance of CFU-GEMM colonies.
The greater differentiation and clonogenic potential we
observed when compared to that of Natan et al. may be directly
related to the presence of intracellular trehalose. The results
presented here show that transfer of trehalose into HPC was
sufficient to maintain cell function during drying, storage at 25uC
for 4 weeks, and reconstitution.
We propose that trehalose protects cells by the following
mechanisms: (1) during cooling, ice nucleation occurs in the
extracellular environment while the intracellular water supercools.
Because of extracellular ice formation, solute concentrations are
higher outside the cells than inside. As a result, water diffuses out
of the cell. The cells dehydrate sufficiently such that intracellular
ice formation does not occur. (2) As the temperature continues to
decrease, the unfrozen solution within cells and the extracellular
unfrozen fraction solidify into glass. The viscosity is sufficiently
high to reduce molecular motion on a practical time scale. (3) The
glass is maintained during desiccation and continues to protect
cells during storage in the dried state. (4) Due to the relatively high
amount of residual water, approximately 6.5%, for cells processed
at 15uC, it would be unlikely that the water replacement
hypothesis (see below) explains a mechanism of protection for
cells processed at 15uC. In this case, the residual water could
maintain hydration of biomolecules and serve to reduce damage
during the drying and storage.
However, samples exposed to secondary drying at 20uC had
approximately 1.8% residual water. For these cells in these
samples, the water replacement hypothesis is a reasonable
mechanism. The water replacement hypothesis suggests that
adding trehalose before drying lowers the transition temperature
(Tm) of the dry membranes by replacing the water between the
lipid headgroups, preventing the phase transition and its
accompanying leakage upon rehydration[75,76]. Desorption of
water without trehalose increases the headgroup packing of
phospholipid bilayers and forces the acyl chains together,
increasing the probability of van der Waals interactions[77]. As
a result, the lipids may undergo a transition from liquid crystalline
to gel phase[75]. Upon rehydration, dry membranes, which are in
gel phase at room temperature, undergo a transition from gel to
liquid crystal phase. As the membranes pass through this phase
transition there are regions with packing defects, making the
membranes leaky; either due to membrane fusion or the induction
of the hexagonal II phase[78]. In addition to lowering the Tm of
membranes, trehalose and sucrose have been shown to preserve
both structure and function of isolated proteins during dry-
ing[79,80]. This ability to stabilize proteins during drying results
from the disaccharides forming hydrogen bonds with the proteins
when water is removed, thus preventing protein denatur-
ation[81,82,83].
In conclusion, our results demonstrate that high levels of
immature primary HPC derived from UCB can be recovered after
lyophilization and ambient storage when permeabilized with the
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more, improving the levels of mature HPC may be achieved by
optimization of lyophilization processing conditions and the
formulation. This methodology may be utilized with other cells
expressing this pore forming protein. The P2Z receptor present in
the brain is expressed by microglia and ependymal cells rather
than neurons[58]. Since microglia are the resident macrophages of
the brain[84], it is consistent with the finding of the P2Z receptor
in peripheral macrophages and macrophage-like cells found in the
lung and spleen[57]. Expression of this receptor has also been
described in other tissues and systems. For example, primary
human cells such as fibroblasts[85], fetal keratinocytes[86],
vascular endothelial cells [87] and vein smooth muscle[88] have
been permeabilized via P2Z receptor-associated pores. Cells
derived from mice, such as medulla oblongata[89], parotid acinar
cells[90], and spinal cord cells[89] along with immortal microg-
lial[91], astrocytes [92], CHO-K1[91], and mesangial
cells[93],[58] have also been permeabilized with ATP via the
P2Z receptor. However, the most prominent expression is the
hematopoietic tissue: dendritic cells[59,94], duct cells[90], eryth-
rocytes[95] and erythroid progenitors, granulocytes[58], macro-
phages[59], mast cells, monocytes[58,96], neutrophils[64], pe-
ripheral blood mononuclear cells (CD34+)[97], promye-
locytes[64,98], and thymocytes[99] including B lymphocytes[85]
and T lymphocytes[100]. With such a variety of cells already
known to express this protein, there is potentially a wide
application for freeze-drying cells with intracellular trehalose
followed by ambient storage.
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